Mawdsleys joins The Sunday Times Best Places to Work 2026
Mawdsleys joins The Sunday Times Best Places to Work 2026 2nd June 2026

We’re extremely proud to share that Mawdsleys has been recognised by The Sunday Times as one of the UK’s Best Places to Work 2026.

This recognition is especially meaningful because it’s based on the feedback of our colleagues across the business. It reflects the culture we continue to build together where our people feel valued, supported and empowered to grow.

We know that our people are at the heart of everything we do and we remain committed to investing in wellbeing, learning and development, and creating opportunities for everyone to thrive.

Thank you to all our colleagues for your hard work, commitment and for making Mawdsleys such a great place to be.

Other latest news
https://www.mawdsleys.co.uk/news/keeping-medicines-moving-during-contract-change-and-beyond/ thumbnail image Keeping medicines moving during contract change and beyond

We recently sent the last of the Wave 14 contract packs to our hospital customers ready for the contract changeover on 1st June.   They contained all the essentials to help them with the contract change including the all-important, fully checked, Mawdsleys product list complete with EAN, PIP and NPC…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-meabco-launch-a-named-patient-supply-program-for-bp-c1/ thumbnail image Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.   BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

Read more